syndaver
Tampa, US · Delaware corporation · 1 known investors
SynDaver designs and manufactures synthetic humans and anatomical simulators made from water, salts, and fibers that replicate living tissue including muscles, bones, organs, and vessels. Its products serve medical device manufacturers, hospitals, medical and educational institutions, government and military bodies, and industrial customers for uses such as surgical training, medical device testing, education, and product/armor testing.
Founders & leadership
Investors · 1
Competitors · 7
by search overlapCompanies competing with syndaver for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$1MofferedSep 2015 · Manufacturing
- Christopher SakezlesExecutive Officer, Director
- Offering amount
- $1M
- Minimum investment
- $1K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase I | 2022 | $49.4K |
| U.S. Air ForceAir Force | Phase I | 2020 | $49.6K |
| Department of DefenseDefense Health Program | Phase II | 2013 | $977.5K |
| Department of DefenseDefense Health Program | Phase I | 2011 | $145.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.